- Home
- WDH vs ABUS Comparison
WDH vs ABUS Comparison
Compare WDH & ABUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDH
- ABUS
- Stock Information
- Founded
- WDH 2016
- ABUS 2005
- Country
- WDH China
- ABUS United States
- Employees
- WDH N/A
- ABUS N/A
- Industry
- WDH Specialty Insurers
- ABUS Biotechnology: Pharmaceutical Preparations
- Sector
- WDH Finance
- ABUS Health Care
- Exchange
- WDH Nasdaq
- ABUS Nasdaq
- Market Cap
- WDH 564.5M
- ABUS 592.8M
- IPO Year
- WDH 2021
- ABUS N/A
- Fundamental
- Price
- WDH $1.23
- ABUS $3.15
- Analyst Decision
- WDH
- ABUS Strong Buy
- Analyst Count
- WDH 0
- ABUS 4
- Target Price
- WDH N/A
- ABUS $5.50
- AVG Volume (30 Days)
- WDH 358.4K
- ABUS 1.3M
- Earning Date
- WDH 06-04-2025
- ABUS 05-01-2025
- Dividend Yield
- WDH 2.59%
- ABUS N/A
- EPS Growth
- WDH 150.00
- ABUS N/A
- EPS
- WDH 0.14
- ABUS N/A
- Revenue
- WDH $379,748,325.00
- ABUS $6,171,000.00
- Revenue This Year
- WDH N/A
- ABUS $14.57
- Revenue Next Year
- WDH $10.87
- ABUS $15.84
- P/E Ratio
- WDH $8.98
- ABUS N/A
- Revenue Growth
- WDH 5.36
- ABUS N/A
- 52 Week Low
- WDH $0.97
- ABUS $2.63
- 52 Week High
- WDH $1.57
- ABUS $4.72
- Technical
- Relative Strength Index (RSI)
- WDH 43.46
- ABUS 46.31
- Support Level
- WDH $1.20
- ABUS $2.71
- Resistance Level
- WDH $1.30
- ABUS $3.34
- Average True Range (ATR)
- WDH 0.09
- ABUS 0.22
- MACD
- WDH -0.02
- ABUS -0.01
- Stochastic Oscillator
- WDH 18.42
- ABUS 48.89
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. It is a third-party insurance platform in China in terms of life and health insurance.
About ABUS Arbutus Biopharma Corporation
Arbutus Biopharma Corp is a biopharmaceutical company. The company discovers, develops, and commercializes cures for patients suffering from Hepatitis B infection. The company is focused on developing a portfolio of drug candidates with multiple mechanisms of action and is also involved in licensing Lipid nanoparticle technology.